Timotthy B Lowinger

Title: Timotthy B Lowinger: Innovator in Pharmaceutical Chemistry

Introduction

Timotthy B Lowinger is a notable inventor based in Nishinomiya, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the treatment of diseases mediated by raf kinase. His innovative work has led to the development of new therapeutic agents that hold promise for various medical applications.

Latest Patents

Timotthy holds a patent titled "Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas." This invention relates to a group of quinolyl, isoquinolyl, and pyridyl ureas, which are utilized in treating raf-mediated diseases. The patent also covers pharmaceutical compositions that contain these ureas for therapeutic use. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Timotthy is currently associated with Bayer Pharmaceuticals Corporation, where he continues to advance his research and development efforts. His work at Bayer has allowed him to collaborate with leading experts in the field, further enhancing the impact of his inventions.

Collaborations

Some of his notable coworkers include Jacques P Dumas and Bernd Riedl. Their collaborative efforts contribute to the innovative environment at Bayer, fostering advancements in pharmaceutical research.

Conclusion

Timotthy B Lowinger is a distinguished inventor whose work in pharmaceutical chemistry has the potential to transform treatment options for patients. His contributions, particularly in the inhibition of raf kinase, highlight the importance of innovation in addressing complex medical challenges.